Emergent Gets $23 Million Additional Order for Vaccine Production

This post was originally published on this site

[unable to retrieve full-text content]Emergent BioSolutions Inc said late on Sunday that a key U.S. agency has increased an order, related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. The amount will be …